PATHOGENESIS OF COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (FIBRINOLYTIC) STATES .1. SIGNIFICANCE OF FIBRINOGEN PROTEOLYSIS AND CIRCULATING FIBRINOGEN BREAKDOWN PRODUCTS

被引：268

作者：

FLETCHER, AP

SHERRY, S

ALKJAERSIG, N

机构：

来源：

JOURNAL OF CLINICAL INVESTIGATION | 1962年 / 41卷 / 04期

关键词：

D O I：

10.1172/JCI104546

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：896 / &

共 73 条

[1] INHIBITION OF PLASMIN, TRYPSIN AND THE STREPTOKINASE-ACTIVATED FIBRINOLYTIC SYSTEM BY EPSILON-AMINOCAPROIC ACID [J].

ABLONDI, FB ;

HAGAN, JJ ;

PHILIPS, M ;

DERENZO, EC .

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 82 (01) :153-160

[2]

ABOULKER P, 1955, PRESSE MED, V63, P353

[3]

ALAGILLE D, 1956, Sem Hop, V32, P355

[4]

ALKJAERSIG N, 1958, J BIOL CHEM, V233, P81

[5]

ALKJAERSIG N, 1959, J BIOL CHEM, V234, P832

[6] PATHOGENESIS OF COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (FIBRINOLYTIC) STATES .2. SIGNIFICANCE, MECHANISM AND CONSEQUENCES OF DEFECTIVE FIBRIN POLYMERIZATION [J].

ALKJAERSIG, N ;

SHERRY, S ;

FLETCHER, AP .

JOURNAL OF CLINICAL INVESTIGATION, 1962, 41 (04) :917-&

[7] MECHANISM OF CLOT DISSOLUTION BY PLASMIN [J].

ALKJAERSIG, N ;

FLETCHER, AP ;

SHERRY, S .

JOURNAL OF CLINICAL INVESTIGATION, 1959, 38 (07) :1086-1095

[8]

ALKJAERSIG N, UNPUBLISHED

[9]

ALKJAERSIG N, 1961, HENRY FORD HOSPITAL

[10]

BEAUMONT JL, 1956, REV FR ETUD CLIN BIO, V1, P667

← 1 2 3 4 5 6 7 8 →